Specifically, CHB could be correlated with decreased risk of hyperlipidemia and lower prevalence of steatosis, probably due to an elevated serum adiponectin level and increased hepatic lipid accumulation could be induced by HBx overexpression and the observed genetic susceptibility to fatty liver in CHB patients (220). This evidence concerns the gene ADIPOQ and fatty liver disease.